Dr. Lisa Ni explains how proton therapy offers more precision when treating brain and central nervous system tumors in ...
Scientists have taken a new approach to treat brain cancer with the help of two supplements. Elena Popova/Getty Images It may be possible to coax some of the most deadly brain cancer cells into a sort ...
An inexpensive mix of two everyday supplements helped to fight the deadliest brain cancers without a single reported side effect, according to a new study — but researchers say the approach is still ...
Brain tumors cannot always be successfully treated with conventional therapies. A team from Empa and the hospital network HOCH Health Ostschweiz is therefore developing nanozymes that can attack ...
Morning Overview on MSN
New combination therapy achieves unprecedented remission in glioblastoma brain cancer models
Glioblastoma is the most aggressive primary brain cancer in adults, killing most patients within two years of diagnosis ...
Researchers found bacterial genetic and cellular elements inside brain tumor cells that appear biologically active and may influence tumor progression and treatment outcomes These bacterial elements ...
CLEVELAND, Ohio — Whole brain radiotherapy saves lives by treating cancer that has spread to the brain, but it also causes long-standing brain damage. Many patients who go through whole brain ...
Glioblastoma remains a highly challenging malignancy with a pronounced tendency for recurrence. The hypoxic microenvironment ...
A new federal study is investigating whether cell phone radiation can cause cancer, but significant research exploring this question already exists. Here’s what we know. As directed by Health ...
What Is Modeyso Used For? Modeyso is used to treat a type of recurrent brain cancer known as a diffuse midline glioma with a specific genetic mutation known as histone 3 (H3) K27M. Diffuse midline ...
Liz Rudisill put off going to the doctor for years, but once she did, she pushed for her care. Diagnosed with meningioma that ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results